AHSAN NAZIR
Allopathic & Osteopathic Physicians|Internal Medicine HOLLIS, NY NPI 1477543502
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NY Acerta Pharma LLC All categories
General Payments — all program years on this page
$2,530.45
- Category: General Payments
- Program years: PY2018–2024
- Record count: 23
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $986.58 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $986.58 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $364.77 | 3 |
| GlaxoSmithKline, LLC. | $247.38 | 2 |
| ABBVIE INC. | $124.98 | 1 |
| Phathom Pharmaceuticals, Inc. | $124.73 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $124.72 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086157776 | Bayer Healthcare Pharmaceuticals Inc. | $124.72 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104293964 | AstraZeneca Pharmaceuticals LP | $119.79 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104340800 | AstraZeneca Pharmaceuticals LP | $119.98 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105106686 | ABBVIE INC. | $124.98 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105634794 | AstraZeneca Pharmaceuticals LP | $125.00 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116405483 | GlaxoSmithKline, LLC. | $122.69 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116540974 | GlaxoSmithKline, LLC. | $124.69 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151101659 | Phathom Pharmaceuticals, Inc. | $124.73 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.